Based on the above results, we asked whether there are associations between the inflammatory chemokines CCL2 & CCL5 and the inflammatory cytokines TNFα & IL-1β in patients representing different stages along the progression process of breast cancer. This evidence concerns the gene IL1B and breast carcinoma.